Cilia-related signaling pathways, including the SHH, cell cycle–related kinase (CCRK), and histone deacetylase 6 (HDAC6) pathways, are closely correlated with the proliferation, malignant development, and therapeutic resistance of GBM. The gene discussed is HDAC6; the disease is glioblastoma.